Table 2. Frequent and serious adverse... | American Society of Hematology

Table 2.

Frequent and serious adverse events reported during treatment period

Event	Grade 1	Grade 2	Grades 3-4	Total, %
Allergic reaction*	5	5	0	50
Injection site reaction†	6	3	0	45
Upper respiratory‡	7	1	0	40
Headache	6	2	0	40
Fatigue	2	4	0	30
Pneumonia	0	0	2	10
Confusion	0	0	1	5
Back pain	0	0	1	5
Sepsis	0	0	1	5

Event	Grade 1	Grade 2	Grades 3-4	Total, %
Allergic reaction*	5	5	0	50
Injection site reaction†	6	3	0	45
Upper respiratory‡	7	1	0	40
Headache	6	2	0	40
Fatigue	2	4	0	30
Pneumonia	0	0	2	10
Confusion	0	0	1	5
Back pain	0	0	1	5
Sepsis	0	0	1	5

Values reflect events that occurred in more than 20% of patients and all grades 3-4 events. No grade 5 events were reported.

Includes hives, rhinitis, rigors, chills, and dyspnea.

Injection site reactions were dose-dependent.

Includes cough, congestion, infection.